<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04256824</url>
  </required_header>
  <id_info>
    <org_study_id>PR2019-27</org_study_id>
    <nct_id>NCT04256824</nct_id>
  </id_info>
  <brief_title>Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds</brief_title>
  <official_title>Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ClinAmygate</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Misr University for Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Al Safwa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Al Zohour Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Al-Menia Univeristy Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MSKMC Univeristy Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ClinAmygate</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan
      and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin
      910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in
      clean-contaminated wound surgery. Also, comparing the post hospital stay.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2020</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized-controlled study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of surgical site infection within 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>duration of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">430</enrollment>
  <condition>Surgical Site Infection</condition>
  <condition>Surgical Wound</condition>
  <condition>Surgical Wound Infection</condition>
  <arm_group>
    <arm_group_label>Coated Polyglactin 910 with Triclosan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coated vicryl plus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coated Polyglactin 910 without Triclosan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coated vicryl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>coated vicryl plus</intervention_name>
    <description>Coated Polyglactin 910 with Triclosan (coated vicryl plus)</description>
    <arm_group_label>Coated Polyglactin 910 with Triclosan</arm_group_label>
    <other_name>Coated Polyglactin 910 with Triclosan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vicryl</intervention_name>
    <description>Coated Polyglactin 910 without Triclosan (vicryl)</description>
    <arm_group_label>Coated Polyglactin 910 without Triclosan</arm_group_label>
    <other_name>Coated Polyglactin 910 without Triclosan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18-75

          -  clean-contaminated wound surgery

        Exclusion Criteria:

          -  Patient has immunodeficiency disorder.

          -  Patient receiving anti-cancer / immunosuppressive therapy.

          -  Patients with established pre-operative infection whether community acquired or
             hospital acquired either at / remote from the operative site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emad R Issak, Diploma</last_name>
    <role>Study Director</role>
    <affiliation>ClinAmygate</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emad R Issak, Diploma</last_name>
    <phone>00201272228989</phone>
    <email>dr.emad.r.h.issak@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Misr Univeristy for Science and Technology Hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moatasem-Bellah A Erfaan, MD</last_name>
      <phone>01223478555</phone>
      <email>mustmedicine@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Ahmed I, Boulton AJ, Rizvi S, Carlos W, Dickenson E, Smith NA, Reed M. The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature. BMJ Open. 2019 Sep 3;9(9):e029727. doi: 10.1136/bmjopen-2019-029727.</citation>
    <PMID>31481559</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>July 19, 2020</last_update_submitted>
  <last_update_submitted_qc>July 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triclosan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

